Clinical Trial Update: Randomized Study of Gonadotropin-releasing-hormone Agonist (GnRH-a) or Expectant Management for Endometriosis [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial compares a gonadotropin-releasing-hormone agonist with expectant management for endometriosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Gonadotropin-releasing-hormone agonist (GnRH agonist) (GnRH agonist)

Snippet

Sponsor: Zhejiang University | Conditions: Endometriosis | Phase 4 | Status: UNKNOWN